1999
DOI: 10.1002/(sici)1099-1573(199909)13:6<535::aid-ptr526>3.0.co;2-w
|View full text |Cite
|
Sign up to set email alerts
|

Activities of silymarin and its flavonolignans upon low density lipoprotein oxidizability in vitro

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
24
1
1

Year Published

2000
2000
2016
2016

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 46 publications
(27 citation statements)
references
References 8 publications
1
24
1
1
Order By: Relevance
“…The antioxidant eff ect is due to the modulation of pathways such as cell growth, apoptosis and diff erentiation (6).…”
Section: Introductionmentioning
confidence: 98%
“…The antioxidant eff ect is due to the modulation of pathways such as cell growth, apoptosis and diff erentiation (6).…”
Section: Introductionmentioning
confidence: 98%
“…This causes impairments of liver function which can affect crucial cellular processes leading to hepatocellular injury [20,27]. It has been shown that silymarin protected against the CCl 4 -induced hepatotoxicity through scavenging free radicals and reactive oxygen species [13,22]. Furthermore, anti-inflammatory and anti-fibrotic properties have been described (reviewed in [1]).…”
Section: Introductionmentioning
confidence: 99%
“…), is a mixture of flavonolignans including silybin, silychristin, isosilybin, silydianin, taxifolin, and various derivatives of these components (1)(2)(3). Silymarin as well as silybin, the main active component comprising about 33% of total silymarin weight (4), is used clinically as a hepatoprotector to treat liver injuries and chronic hepatitis.…”
Section: Introductionmentioning
confidence: 99%